Loading clinical trials...
Loading clinical trials...
Zenith® Fenestrated AAA Endovascular Graft Clinical Study
The Zenith®Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of California, San Francisco
San Francisco, California, United States
Shands Hospital
Gainesville, Florida, United States
University of Florida
Gainesville, Florida, United States
The Indiana Heart Hospital
Indianapolis, Indiana, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
University of Massachusetts Medical School
Worcester, Massachusetts, United States
Mayo Clinic Rochester
Rochester, Minnesota, United States
Barnes-Jewish Hospital
St Louis, Missouri, United States
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
NYU Medical Center
New York, New York, United States
Last Updated
November 24, 2017
Zenith® Fenestrated AAA Endovascular Graft
DEVICE
Lead Sponsor
Cook Group Incorporated
NCT07184723
NCT06710938
NCT06884397
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions